Loading clinical trials...
Loading clinical trials...
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital
Conditions
Interventions
Tonlamarsen
Placebo
Locations
1
United States
Progressive Medical Research
Port Orange, Florida, United States
Start Date
April 20, 2026
Primary Completion Date
December 29, 2026
Completion Date
February 23, 2027
Last Updated
April 6, 2026
NCT06647511
NCT05746039
NCT07439939
NCT07218029
NCT06741436
NCT07098065
Lead Sponsor
Kardigan, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions